NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Thursday that revenues for the first quarter of its Fiscal Year 2014 were flat year over year while Life Sciences and Diagnostics revenues ticked up 5 percent.

For the three months ended Jan. 31, total revenues of $1.68 billion narrowly missed the consensus Wall Street estimate of $1.69 billion. Orders of $1.68 billion were down 2 percent from $1.71 billion a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.